PROKIDNEY CORP.

PROK

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001850270

SEC filings (opens in a new tab)

Insider trades, last 90 days

0 buys · 1 sell

Sold $1.07M
Open-market purchases (P) and sales (S), counted by Form 4 filing.

View insider trades

13F holders, Q2 2026

71

0 vs. Q1 2026
Total value $99.45M

View 13F holders

Superinvestors holding PROK

0

None of the superinvestors held PROK at the end of Q2 2026.

See all holders

Price chart

Chart by TradingView (opens in a new tab)

Latest insider trades

Open-market purchases and sales by PROK insiders, newest first.

Insider trades
Filed (ET)	Trade date	Insider	Transaction	Shares	Avg price	Value	Shares after	Holding change	Filing
Aug 20, 20265:00 PM ET	Aug 18 – Aug 20, 2026	Pereira Brian JGDirector	SSaleClass A Common Stock	−675.24K	$1.4102	−$952.23K	0	−100.0%	SEC
Aug 20, 20265:00 PM ET	Aug 18 – Aug 20, 2026	Pereira Brian JGDirector	SSaleClass A Common Stock	−81.93K	$1.4102	−$115.54K	0	−100.0%	SEC
Nov 14, 2025	Nov 12 – Nov 13, 2025	Pereira Brian JGDirector	SSaleClass A Common Stock	−757.16K	$2.4879	−$1.88M	0	−100.0%	SEC
Jul 9, 2025	Jul 8, 2025	Weber Darin J.Chief Regulatory Officer	SSaleClass A Common Stock	−103.48K	$3.02	−$312.51K	0	−100.0%	SEC10b5-1
Apr 24, 2025	Apr 22, 2025	Control Empresarial de Capitales S.A. de C.V.10% Owner, Other: Add'l Rep. Persons-see Ex.99-1	PPurchaseClass A Ordinary Shares (as defined in Exhibit 99.1 hereto)	+387.39K	$0.71	+$275.05K	73.84M	+0.5%	SEC

Top 5 13F holders, Q2 2026

The largest institutional positions in PROK at the end of Q2 2026.

Institutions holding PROK in Q2 2026
Institution	Shares	Value	% of portfolio	Change in shares	Action
SUVRETTA CAPITAL MANAGEMENT, LLC	12,341,266	$25.18M	0.53%	00.0%	Unchanged
MORGAN STANLEY	9,854,178	$20.1M	0.00%	+898,211+10.0%	Added
BlackRock, Inc.	5,197,227	$10.6M	0.00%	+3,810,111+274.7%	Added
GEODE CAPITAL MANAGEMENT, LLC	2,390,147	$4.88M	0.00%	+1,159,738+94.3%	Added
Bleichroeder LP	2,000,000	$4.08M	0.73%	00.0%	Unchanged